The study on adriamycin induced DNA scissions in human cells with different activity of some antioxidant enzymes

B Chłopkiewicz1, B Gruber

  • 1Drug Institute, 30/34 Chełmska Str., 00-725 Warsaw, Poland.

Acta Poloniae Pharmaceutica
|December 29, 2000
PubMed

Insights

Adriamycin treatment caused similar DNA breaks in human cells, regardless of antioxidant enzyme levels. This suggests adriamycin

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Adriamycin (doxorubicin) is a widely used anthracycline antibiotic for various human malignancies.
  • Its precise biological activity mechanism remains largely unknown.
  • A proposed mechanism involves the generation of reactive oxygen species (ROS) leading to DNA damage.

Purpose of the Study:

  • To investigate if adriamycin-induced DNA breaks are dependent on intracellular antioxidant enzyme levels.
  • To explore the role of catalase and superoxide dismutase in adriamycin's DNA-damaging effects.

Main Methods:

  • Utilized two human cell lines (CRL2088 and CLV102) with differing catalase and superoxide dismutase activity.
  • Treated cell lines with adriamycin.
  • Assessed and compared the occurrence of DNA breaks in both cell lines.

Main Results:

  • Similar levels of adriamycin-induced DNA breaks were observed in both cell lines.
  • The observed DNA damage was consistent despite significant differences in antioxidant enzyme activity between the cell lines.

Conclusions:

  • Intracellular levels of catalase and superoxide dismutase do not appear to significantly influence adriamycin-induced DNA breaks.
  • The findings suggest that antioxidant enzymes may not be the primary determinant of adriamycin's DNA-damaging effects in these cell models.